Novavax Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hello. Good morning, and welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Duncan. I'm a Managing Director and Senior Biotechnology Analyst with the firm's equity research department.
And today is day 3 of the annual conference. And I have to say, wow, what a year it has been since we've last hosted our clients in the fall of 2020.
So it's a pleasure to introduce the next presenting company that is Novavax. And with me today, I have Greg Glenn, the Chief Guru or Vaccine Guru, actually the Vice President of R&D. Greg, good morning. Good to see you.
Good morning, Charles.
And I also have John Trizzino, the company's Chief Commercial Officer, who actually used to be the Chief Financial Officer as well. John, nice to see you.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

